PF1 - Quality Assurance and Assessment Lecture Notes

0.0(0)
studied byStudied by 3 people
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/78

encourage image

There's no tags or description

Looks like no tags are added yet.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

79 Terms

1
New cards

Quality Assurance (QA)

A systematic process to ensure reliable, accurate laboratory results, involving policies, procedures, and monitoring to minimize errors.

2
New cards

Components of QA in Laboratory Operations

Patient/client prep, sample collection, pre-analytical phase, analytical phase, and post-analytical phase.

3
New cards

Role of QA Programs

Establishing standardized workflows and protocols

Conducting routine audits and proficiency testing

Training personnel to maintain competency

Compliance with regulatory bodies (e.g., ISO, CLSI, CAP, DOH-HFSRB)

4
New cards

Pre-analytical Errors

Incorrect patient ID and sample contamination.

5
New cards

Analytical Errors

Instrument malfunction and procedural errors.

6
New cards

Post-analytical Errors

Misinterpretation and delayed reporting.

7
New cards

Error Prevention Strategies

Implementing strong internal QC programs, using automation, encouraging ongoing staff training, and promoting a culture of quality.

8
New cards

Quality Control (QC)

Examining “control” materials of known substances along with patient samples to monitor the accuracy and precision of the complete examination (analytic) process.

The goal of QC is to detect errors and correct them before patients’ results are reported.

9
New cards

Quantitative Examination Methods

Measure the quantity of a particular substance in a sample, requiring accuracy and precision.

10
New cards

Qualitative Examination Methods

Examinations that do not have numerical results, such as growth/no growth or positive/negative, reactive/non-reactive, color change

11
New cards

Semi-Quantitative Examination Methods

Results expressed as an estimate of the measured substance, like 'trace amount' or '1+, 2+, or 3+', number of cells per microscopic field, titers and dilutions in serologic tests

12
New cards

Steps for Quantitative QC Implementation

Establish policies, assign responsibility, select high-quality controls, establish control ranges, develop graphs, monitor control values, develop corrective action procedures, and record all actions.

13
New cards

Control

Material that contains the substance being analyzed (include patient samples when performing a test), used to validate the reliability of the test system (run after calibration, run periodically during testing)

14
New cards

Calibrators

A substance with a specific concentration and calibrators are used to set (calibrate) the measuring points on a scale

15
New cards

Controls

Substances similar to patients’ samples with an established concentration and used to ensure the procedure is working properly.

16
New cards

Assayed Controls

Target value pre-determined; requires verification and use.

17
New cards

Unassayed Controls

Target value not pre-determined; requires a full assay before using.

18
New cards

Steps in Implementing Quantitative QC

Obtain control material, run each control 20 times over 30 days, and calculate mean and standard deviations.

19
New cards

Accuracy

The closeness of the measurements to the true value.

20
New cards

Precision

The amount of variation in measurements.

21
New cards

Bias

The difference between the expectation of a test result and an accepted reference value.

22
New cards

Standard Deviation (SD)

Principle measure of variability used in the laboratory.

23
New cards

Coefficient of Variation

Used to monitor precision and compare methods, ideally less than 5%.

24
New cards

Levey-Jennings Chart

Graphically representing control ranges over a 20-30 day period to ensure procedural variation is represented and calculate mean and SD

25
New cards

Random Error

Variation in QC results with no pattern; only a cause for rejection if outside 2SDs.

26
New cards

Systematic Error

Not acceptable- shift and trend.

27
New cards

External Quality Assessment (EQA)

A system for objectively checking the laboratory’s performance using an external agency or facility.

28
New cards

EQA method: Proficiency Testing

An external provider sends unknown samples for testing to a set of laboratories; results are analyzed, compared and reported to the laboratories

29
New cards

EQA Methods

Comparison among different test sites, early warning for systemic problems, objective evidence of testing quality, areas that need improvement and training needs

30
New cards

On-Site Evaluation

A periodic visit by evaluators for on-site laboratory assessment is a type of EQA that has been used when other methods of EQA are not feasible/effective

31
New cards

EQA Management Process

Includes handling of samples, analyses of samples, appropriate record keeping, investigation of deficiencies, taking corrective action, and communication of outcomes.

32
New cards

EQA Performance Problems (Pre-Analytical)

Sample may have been compromised during preparation, shipping, or after receipt in the laboratory by improper storage or handling

33
New cards

EQA Performance Problems (Analytical)

The EQA challenge materials may exhibit a matrix eect in the examination system used by the participating laboratory

34
New cards

EQA Performance Problems (Analytical)

Possible sources of analytical problems include reagents, instruments, test methods, calibrations and calculations

35
New cards

EQA Performance Problems (Analytical)

Competency of sta will need to be considered and evaluated

36
New cards

EQA Performance Problems (Analytical)

Analytical problems should be investigated to determine whether error is random or systematic.

37
New cards

EQA Performance Problems (Post-Analytical)

The report format can be confusing, Interpretation of results can be incorrect and Clerical or transcription errors can be sources of error.

38
New cards

EQA Performance Problems (Pre-Analytical)

The sample may have been processed or labelled improperly in the laboratory

39
New cards

Quality Assurance (QA)

Involves policies, procedures, and monitoring to minimize errors.

40
New cards

Importance of QA in Laboratory Operations

Ensures patient safety, improves efficiency and consistency in testing and enhances regulatory compliance.

41
New cards

Laboratory operations (pre-analytical phase)

Personal Competency Evaluations

Sample Receipt and Accessioning

Sample Transport

42
New cards

Laboratory operations (analytical phase)

Quality Control Testing

43
New cards

Laboratory operations (post-analytical phase)

Record Keeping

Reporting

44
New cards

internal QC programs (error preventing strategies)

Routine QC Testing

Instrument calibration and Maintenance

Implementation and strict adherence to standard operating procedures (SOPs)

Data monitoring and Statistical analysis

45
New cards

Consequences of impact of lab errors on patient outcomes

Misdiagnosis and incorrect treatment

Delayed interventions

Increased healthcare costs and patient dissatisfaction.

46
New cards

Quality assurance

not a one-time process; it’s an ongoing commitment to excellence

47
New cards

CHARACTERISTICS OF CONTROL MATERIALS

Appropriate for the diagnostic sample

Values cover medical decision points

Similar to test sample

Available in large quantity

Ideally enough for one year

Can store in small aliquots

48
New cards

Control materials (types of control materials)

May be frozen, freeze- dried, or chemically preserved

Requires very accurate reconstitution if this step is necessary.

49
New cards

Control materials (sources of control materials)

Commercially prepared

Made “in house”

Obtained from another laboratory, usually central or reference laboratory

50
New cards

IN-HOUSE CONTROLS

pooled sera

Full assay, validation

51
New cards

CHOOSING CONTROL MATERIALS

Values cover medical decision points similar to the test sample

Controls are usually available in high, normal, and low ranges

52
New cards

PREPARATION AND STORAGE OF CONTROL MATERIAL

Adhere to manufacturer’s instructions

Keep adequate amount of same lot number

Store correctly

53
New cards

MEASUREMENT OF VARIABILITY

Variability is a normal occurrence when a control is tested repeatedly

Aected by: ○ Operator technique ○ Environmental conditions ○ Performance characteristics of the measurement

The goal is to dierentiate between variability due to chance from that due to error

54
New cards

MEASUREMENT OF VARIABILITY - MODE

The value which occurs with the greatest frequency

55
New cards

MEASUREMENT OF VARIABILITY - MEDIAN

The value at the center or midpoint of the observations

56
New cards

MEASUREMENT OF VARIABILITY - MEAN

The calculated average of the values

57
New cards

NORMAL DISTRIBUTION

All values symmetrically distributed around the mean

Characteristic “bell-shaped” curve

Assumed for all quality control statistics

58
New cards

STANDARD DEVIATION

Principle measure of variability used in the laboratory

59
New cards

INTERPRETATION OF CONTROLS

Dependent on the number of controls run with patients' samples.

When using only one QC sample: Values outside 2 SD = out of control = reject

If it is possible to use only one control, choose one with a value that lies within the normal range of the analyte being tested. When evaluating results, accept all runs where the control lies within +2 SD.

In order to improve efficiency and accuracy, a system using two or three controls for each run can be employed: Apply Westgard multirole system.

60
New cards

QC TROUBLESHOOTING

If QC is out of control: STOP testing

Identify and correct problem

Repeat testing on patient samples and controls after correction

Do not report patient results until the problem is solved and controls indicate proper performance

61
New cards

BASIC TROUBLESHOOTING (QC OUT OF LIMITS - ACTIONS TO BE TAKEN)

If unresolved - Repeat with the same vial

If unresolved - Repeat with new vial

If unresolved - Repeat with new reagents

If unresolved - Recalibrate If unresolved Refer to support

62
New cards

SOURCES OF ERROR AND POSSIBLE REASONS

RANDOM ERROR - SYSTEMATIC ERROR

Unstable power supply - Improper alignment of probes

Double pipetting of sample - Drift/shift in incubation temperature

Air bubbles in water supply - Change in reagent lot number

Air bubbles in reagent/sample - Deterioration of reagent

Operator technique - Use of non-compliant consumables

- Recent calibration

- Change in test procession

- Improper handling of reagents

63
New cards

EQA method: Rechecking or retesting

slides that have been read are rechecked by a reference laboratory; samples that have been analyzed are retested, allowing for interlaboratory comparison.

64
New cards

EQA method: on-site evaluation

usually done when it is difficult to conduct traditional proficiency testing or to use the rechecking/retesting method.

65
New cards

EQA

important for improvement of the laboratory QMS, as it is a measure of lab performance

66
New cards

ISO/IEC GUIDE 43-1:1997

“Proficiency testing schemes (PTS) are interlaboratory comparisons that are organized regularly to assess the performance of analytical laboratories and the competence of the analytical personnel.”

67
New cards

CLSI GP27-A2 27:8

“A program in which multiple samples are periodically sent to members of a group of laboratories for analysis and/or identification; whereby each laboratory’s results are compared with those of other laboratories in the group and/or with an assigned value, and reported to the participating laboratories and others.”

68
New cards

Lung Center of the Philippines

Clinical Chemistry

69
New cards

San Lazaro Hospital

National Reference Laboratory/STD AIDS Cooperative Central Laboratory (SLH-NRL/SACCL)

70
New cards

ROLES OF LABORATORY

Information received from PT participation must be directed toward improvement in the laboratory to receive the full value.

71
New cards

PROFICIENCY LIMITATIONS

PT results are affected by variables not related to patient samples.

PT will not detect all problems in the laboratory.

PT may not detect problems with pre- and post examination procedures

72
New cards

other QA methods - RETESTING

Tested by reference laboratory

Performed on serum

Not blinded

Statically significant

73
New cards

other QA methods - RECHECKING

Samples must be collected randomly

Avoid systematic sampling bias

Satirically significant

Resolve discrepancies

Effective feedback

74
New cards

ON-SITE EVALUATION

Obtain a realistic picture of laboratory practices by observing the laboratory under routine conditions in order to check that it is meeting quality requirements.

Provide information for internal process improvement.

Measure gaps or deficiencies—learn “where we are”;

Assist the laboratory in collecting information for planning and implementation of training, monitoring and corrective actions

75
New cards

management process - handling of samples

These will need to be logged, processed properly and stored as needed for future use.

76
New cards

management process - analyses of samples

Consider whether EQA samples can be tested so that sta do not recognize them as dierent from patient samples (blinded testing).

77
New cards

management process - appropriate record keeping

Records of all EQA testing reporting should be maintained over a period of time, so that performance improvement can be measured.

78
New cards

management process - investigation of any deficiencies

For any challenges where performance is not acceptable.

79
New cards

management process - taking corrective action when performance is not acceptable

The purpose of EQA is to allow for detection of problems in the laboratory, and to therefore provide an opportunity for improvement.